Mentions
Extended reach
Total likes
Video views
AI synopsis
The digital discussions consist of supportive comments about the review, with many highlighting how medications can improve weight loss outcomes, and some referencing specific drugs like semaglutide or tirzepatide. The tone is generally informative and engaged, emphasizing the importance of understanding drug mechanisms and safety, which underscores the review's potential impact on medical practice.
Many discussions recognize the review's usefulness and highlight the effectiveness of medications, indicating general support.
Posts show high curiosity about the mechanisms, safety, and new medications, reflecting genuine engagement with the topic.
Users delve into mechanisms of action and safety concerns, demonstrating thoughtful analysis and detailed responses.
Multiple posts reference clinical implications, suggesting the publication influences perceptions of obesity treatment and policy.
Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/jama.2024.10816 https://t.co/yyRTI18FzD
Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4QEVqdZuL https://t.co/uJREgVInPl
Porcentaje de pérdida de peso con el uso de medicamentos para el manejo de la obesidad.
肥満の薬物治療のレビュー チルゼパチド（マンジャロ）が代表ですが、肥満代謝はしばらくトレンドの中心になりそうですね。 しかし多臓器に結果を出してくるあたりは病態の本質をついてきてるのかなとSLGT-2阻害薬とともに実感します。 Medications for Obesity A Review JAMA https://t.co/nPOROaWNM0
New weight loss drugs have transformed care for people with obesity. This podcast discusses prescribing these drugs to improve health outcomes and minimize adverse effects in people with obesity.
Today, we discuss Tirzepatide, a medication used for obesity and diabetes. It offers promising results by affecting appetite regulation and promoting weight loss, supported by recent clinical research and systematic…
Medications for Obesity https://t.co/8OF8WfLG57
Medications for Obesity: Nutrient-stimulated hormone-based medications, as liraglutide, semaglutide, tirzepatide, mimic actions of enteropancreatic hormones that modify central appetite regulation & provide multiple cardiometabolic weight-loss benefits. https://t.co/BBeSh2YG25
RT @endotips: Porcentaje de pacientes que alcanzan >5, >10, >15, >20 y >25% de disminución de peso con el uso de orlistat, fentermina-topir…
RT @endotips: Medications for Obesity: A Review.
Medications for Obesity: A Review | Obesity | JAMA | JAMA Network https://t.co/Ad3aeoYhYB
RT @JAMAInternalMed: @SocietyGIM Antiobesity medications may improve weight loss and health outcomes by altering biological processes relat…
RT @JAMAInternalMed: @SocietyGIM Antiobesity medications may improve weight loss and health outcomes by altering biological processes relat…
@SocietyGIM Antiobesity medications may improve weight loss and health outcomes by altering biological processes related to appetite. ➡️ This Review summarizes the efficacy and safety of #AOMs. https://t.co/bZYudlPtmn #GLP1 #SGIM25 https://t.co/VXJyGYLv0a
Medications for Obesity: A Review https://t.co/bE5qTKTxQA via @gudzune et al https://t.co/L6byJzpsEI
RT @endotips: Porcentaje de pérdida de peso con el uso de medicamentos para el manejo de la obesidad.
RT @endotips: Porcentaje de pérdida de peso con el uso de medicamentos para el manejo de la obesidad.
RT @endotips: Porcentaje de pérdida de peso con el uso de medicamentos para el manejo de la obesidad.
RT @endotips: Porcentaje de pérdida de peso con el uso de medicamentos para el manejo de la obesidad.
Porcentaje de pérdida de peso con el uso de medicamentos para el manejo de la obesidad.
RT @VivekSubbiah: Medications for Obesity @JAMA_current https://t.co/Be9XDqOwUj
Medications for Obesity @JAMA_current https://t.co/Be9XDqOwUj
RT @VeraZertucheMD: Mecanismos de acción de los fármacos para tratar obesidad. Revisión muy completa publicada en JAMA https://t.co/AY1l8h…
RT @ApoSpecialtyRx: Medications for Obesity: A Review | JAMA https://t.co/jZe1Hp7tbg #Sausalito #SanDiego #SanFrancisco #BeverlyHills #Sant…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @SANCYDnutricion: Medicamentos para la obesidad
RT @SANCYDnutricion: Medicamentos para la obesidad
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @drkeithsiau: Medications for obesity
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
Medicamentos para la obesidad
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @Paul_Wischmeyer: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity H/T @NutrioSci Read more https://t.co/OfyLN…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @Paul_Wischmeyer: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity H/T @NutrioSci Read more https://t.co/OfyLN…
Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity H/T @NutrioSci Read more https://t.co/OfyLNyLcHc https://t.co/YVNmuGskBn
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
@BradMossEsq Medical studies confirm that the use of several of these drugs work far better than diet & exercise alone and can facillitate better diets & more exercise in combination. https://t.co/MnLf6ad9AZ
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4Q…
Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/q4QEVqdZuL https://t.co/uJREgVInPl
RT @ApoSpecialtyRx: Medications for Obesity | JAMA https://t.co/jZe1Hp7tbg #SanDiego #ManhattanBeach #Zepbound #SanFrancisco #BeverlyHills…
RT @ObesitySeen: Nuevo artículo de revisión en JAMA sobre el tratamiento farmacológico de la obesidad https://t.co/b9nX5pjn3h
RT @ObesitySeen: Nuevo artículo de revisión en JAMA sobre el tratamiento farmacológico de la obesidad https://t.co/b9nX5pjn3h
RT @VeraZertucheMD: Mecanismos de acción de los fármacos para tratar obesidad. Revisión muy completa publicada en JAMA https://t.co/AY1l8h…
Medications for Obesity | JAMA https://t.co/jZe1Hp7tbg #SanDiego #ManhattanBeach #Zepbound #SanFrancisco #BeverlyHills #SantaBarbara #SantaMonica #NewportBeach #Manhattan #SiliconValley #MarinCounty #NewYorkCity #NYC #Mounjaro #Wegovy #Ozempic #PalosVerdesPeninsula #RanchoSantaFe https://t.co/aDTGoF3wmF
Medications for Obesity: A Review | JAMA https://t.co/jZe1Hp7tbg #Sausalito #SanDiego #SanFrancisco #BeverlyHills #SantaBarbara #SantaMonica #NewportBeach #Manhattan #SiliconValley #MarinCounty #newyorkcity #NYC #Mounjaro #Wegovy #Malibu #LaJolla #Zepbound #Hollywood #Ozempic https://t.co/3pVK3mpXOI
RT @drkeithsiau: Medications for obesity
RT @JasmineNephro:
Medications for #Obesity: A Review | Obesity | JN Learning | AMA Ed Hub https://t.co/i9OMHXbZiQ
RT @JasmineNephro:
Mecanismos de acción y principales efectos adversos de medicamentos usados para la obesidad.
RT @agingdoc1: Medications for Obesity A Review
RT @JasmineNephro:
RT @agingdoc1: Medications for Obesity A Review
RT @JasmineNephro:
RT @JasmineNephro:
Mechanisms of Action & Common Adverse Effects of 3 Classes of Antiobesity Medication Medications for Obesity: A Review | Obesity | JAMA https://t.co/jZe1Hp7tbg #NewportBeach #SiliconValley #LosAngeles #SantaMonica #SantaBarbara #BeverlyHills #SouthernCalifornia #SanDiego #LaJolla https://t.co/wSgDBvDFmn
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JasmineNephro:
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
Medications for Obesity A Review
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JasmineNephro:
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JasmineNephro:
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JasmineNephro:
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JasmineNephro:
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JasmineNephro:
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JasmineNephro:
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JasmineNephro:
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
RT @JAMA_current: Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medication…
#Obesidad
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @endotips: Porcentaje de pacientes que alcanzan >5, >10, >15, >20 y >25% de disminución de peso con el uso de orlistat, fentermina-topir…
RT @CristobMorales: https://t.co/IkH4Eihzc8 Medications for Obesity A Review @JAMANetwork @SociedadSeedo @EASOobesity https://t.co/o38ccmJY…
RT @DrAkhilRaghavan:
RT @DrAkhilRaghavan:
RT @CristobMorales: https://t.co/IkH4Eihzc8 Medications for Obesity A Review @JAMANetwork @SociedadSeedo @EASOobesity https://t.co/o38ccmJY…
RT @docalok: Medications for Obesity: A Review | Obesity | JAMA | JAMA Network @iapindia @AdolHealthIAP @fogsiofficial @IMAIndiaOrg…
RT @docalok: Medications for Obesity: A Review | Obesity | JAMA | JAMA Network @iapindia @AdolHealthIAP @fogsiofficial @IMAIndiaOrg…
RT @DrAkhilRaghavan:
RT @DrAkhilRaghavan:
RT @DrAkhilRaghavan:
RT @rksanti:
RT @Yohei_Kanzawa: 肥満の薬物治療のレビュー チルゼパチド（マンジャロ）が代表ですが、肥満代謝はしばらくトレンドの中心になりそうですね。 しかし多臓器に結果を出してくるあたりは病態の本質をついてきてるのかなとSLGT-2阻害薬とともに実感します。 Medi…
肥満の薬物治療のレビュー チルゼパチド（マンジャロ）が代表ですが、肥満代謝はしばらくトレンドの中心になりそうですね。 しかし多臓器に結果を出してくるあたりは病態の本質をついてきてるのかなとSLGT-2阻害薬とともに実感します。 Medications for Obesity A Review JAMA https://t.co/nPOROaWNM0
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @DrAkhilRaghavan:
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/s62…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/s62…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/s62…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/s62…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/s62…
RT @NutrioSci: Medications for Obesity: A Review @JAMA_current #MedEd #MedX #obesity Read more https://t.co/0pFLI8FIwK https://t.co/s62…
RT @endotips: Medications for Obesity: A Review.
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @endotips: Medications for Obesity: A Review.
RT @endotips: Porcentaje de pacientes que alcanzan >5, >10, >15, >20 y >25% de disminución de peso con el uso de orlistat, fentermina-topir…
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
Medications for Obesity: A Review | Obesity | JAMA | JAMA Network https://t.co/dtd3TNb8ef
【総説】肥満治療薬 #ペ読 https://t.co/NKcRDmea17
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @rksanti:
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @rksanti:
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @rksanti:
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @rksanti:
RT @rksanti:
RT @rksanti:
RT @MedClubPage: #Endocrinología #MedicinaInterna Mecanismos de acción y efectos adversos de las 3 clases de medicamentos para la obesidad.…
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @MedClubPage: #Endocrinología #MedicinaInterna Mecanismos de acción y efectos adversos de las 3 clases de medicamentos para la obesidad.…
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @MedClubPage: #Endocrinología #MedicinaInterna Mecanismos de acción y efectos adversos de las 3 clases de medicamentos para la obesidad.…
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @rksanti:
RT @MedClubPage: #Endocrinología #MedicinaInterna Mecanismos de acción y efectos adversos de las 3 clases de medicamentos para la obesidad.…
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @rksanti:
RT @endotips: Porcentaje de pacientes que alcanzan >5, >10, >15, >20 y >25% de disminución de peso con el uso de orlistat, fentermina-topir…
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @rksanti:
RT @rksanti:
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @rksanti:
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @rksanti:
RT @rksanti:
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @MedClubPage: #Endocrinología #MedicinaInterna Mecanismos de acción y efectos adversos de las 3 clases de medicamentos para la obesidad.…
RT @rksanti:
RT @MedClubPage: #Endocrinología #MedicinaInterna Mecanismos de acción y efectos adversos de las 3 clases de medicamentos para la obesidad.…
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @MedClubPage: #Endocrinología #MedicinaInterna Mecanismos de acción y efectos adversos de las 3 clases de medicamentos para la obesidad.…
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @AmbrizMau: Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/…
RT @rksanti:
RT @rksanti:
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @rksanti:
RT @rksanti:
Mecanismos de acción y efectos adversos comunes de tres clases de medicamentos contra la obesidad: JAMA 2024; DOI: 10.1001/jama.2024.10816 https://t.co/yyRTI18FzD
RT @MHcsba: JAMA 2024: Obesidad y su manejo #MedEd #MedTwitter #MedX doi:10.1001/jama.2024.10816 https://t.co/L4hsxixHwy
RT @rksanti:
RT @MedClubPage: #Endocrinología #MedicinaInterna Mecanismos de acción y efectos adversos de las 3 clases de medicamentos para la obesidad.…
RT @MedClubPage: #Endocrinología #MedicinaInterna Mecanismos de acción y efectos adversos de las 3 clases de medicamentos para la obesidad.…
RT @davearterburn: Medications for Obesity: A Review https://t.co/nofWTF0mrl
RT @davearterburn: Medications for Obesity: A Review https://t.co/nofWTF0mrl
RT @davearterburn: Medications for Obesity: A Review https://t.co/nofWTF0mrl
Medications for Obesity: A Review https://t.co/nofWTF0mrl
2024;30(7):2049-2057. doi:10.1038/s41591-024-02996-7. 24.Gudzune KA, Kushner RF. Medications for obesity. JAMA. 2024;332(7):571. doi:10.1001/jama.2024.10816 ...
Medications for obesity: a review. JAMA. 2024. https://doi.org/10.1001/jama.2024.10816 entirely due to the loss of fat. Weight loss of any kind ...
JAMA. 2024;332(7):571-584. 0003-4819-157-9-201211060-00003 smoking in human cancer. Science. 2016;354(6312): doi:10.1001/jama.2024.10816 618-622. doi ...
DOI: 10.1001/jama.2024.10816. 2014.243. 229. Sjöström, L., Rissanen, A., Andersen, T., et al. (1998). Randomised ...
Family Medicine Ramathibodi added a photo to the album: Recap.FMRAMA2025. Apr 24
doi:10.1001/jama.2024.10816. 3. Elmaleh-Sachs A et al. JAMA. 2023;330(20):2000-2015. doi:10.1001/jama.2023.19897. 4. Jastreboff AM et al ...
doi:10.1001/jama.2023.24945 3. Gudzune KA et al. JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816 #Tirzepatida #Mounjaro #Obesidad ...
JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816. 2. Adipex-P / stimulants safety profile. Food and Drug Administration. Updated 2024 ...
JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816. 2. Adipex-P / stimulants safety profile. Food and Drug Administration. Updated 2024 ...
JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816. 2. Adipex-P / stimulants safety profile. Food and Drug Administration. Updated 2024 ...
doi: 10.1001/jama.2024.10816. 17. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Feb.
JAMA. 2024;332(7):571-584. doi: 10.1001/jama.2024.10816. 5. Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as Compared with Semaglutide ...
JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816. 2. ADA. Standards of Care in Diabetes 2025. Diabetes Care. 2025;48(Suppl 1):S167 ...
Gudzune KA, Kushner RF. Medications for Obesity: A Review. JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816. ⸻ Hashtags ...
JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816. 3. Jastreboff AM, le Roux CW, Stefanski A, et al. Tirzepatide for obesity treatment ...
Gudzune KA, Kushner RF. Medications for obesity: a review. JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816; FDA approves treatment for ...
JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816. 2. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for ...
JAMA. 2024;332(7):571–584. doi:10.1001/ jama.2024.10816, 8. Garvey WT. J Clin Endocrinol Metab. 2022;107(4):e1339-e1347. MOUNJARO KWIKPEN ...
doi:10.1001/jama.2024.10816. 4. Dahl D, Onishi Y, Norwood P, et al. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin ...
doi:10.1001/jama.2024.10816 2. FDA Adipex-P Prescribing Information ... doi:10.1001/jama.2024.10816 3. Zhao L, et al. JAMA. 2024;332(7): ...
doi:10.1001/jama.2024.10816. 2. ADA. Standards of Care in Diabetes 2025. Diabetes Care. 2025;48(Suppl 1):S167-S180. doi:10.2337 ...
doi:10.1001/jama.2024.10816. 3. Elmaleh-Sachs A, Schwartz JL, Bramante CT, et al. Obesity Management in Adults: A Review. JAMA. 2023;330 ...
Medications for Obesity: A Review. JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816. 2. ADA. Standards of Care in Diabetes 2025 ...
JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816. 2. Jastreboff AM, le Roux CW, Stefanski A, et al. Tirzepatide for Obesity Treatment ...
JAMA. 2024;332(7):571–584. doi:10.1001/jama.2024.10816 #Tirzepatida #Obesidad #Ozempic #PérdidaDePeso #SaludMetabólica #GLP1 # ...
JAMA. 2024;332(7):571–584. doi:10.1001/jama.2024.10816 3. Frias JP et al. NEJM. 2021;385(6):503–515. doi:10.1056/NEJMoa2107519 ...
Medicamentos para el tratamiento de Obesidad JAMA.doi:10.1001/jama.2024.10816.
งานประชุมวิชาการเวชศาสตร์ครอบครัวรามาธิบดีในปี 2569 นี้ จัดทั้งหมด 3 วันนะคะ วันที่ 1-3 เมษายน ที่โรงแรมอีสติน แกรนด์ พญาไท ที่เดิมค่ะ พบกับ session พิเศษ "25 Years of ...
Medications for Obesity: A Review. Gudzune KA, Kushner RF. JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816. 2. Adipex-P / stimulants ...
JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816. 43. Wadden TA, Tronieri JS, Butryn ML. Lifestyle modification approaches for the ...
JAMA. 2024;332(7):571–584. doi:10.1001/jama.2024.10816 2. FDA Adipex-P Prescribing Information. 2024-03-28 3. Apovian CM, Aronne LJ ...
(บทความแปลและสรุปโดย AI ) JAMA Published online December 12, 2024 Antiobesity Medications: ข้อมูลสำคัญและตัวเลือกที่ได้รับการอนุมัติ Obesity...
JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816. 2. Adipex-P / stimulants safety profile. Food and Drug Administration. Updated 2024 ...
JAMA. 2024;332(7):577-584. doi: 10.1001/jama.2024.0186. No photo description available. นูซูลา บินยะปา and ...
JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816. 2. Jastreboff AM, le Roux CW, Stefanski A, et al. Tirzepatide for Obesity Treatment ...
提醒大家，上述藥物都需要醫師評估後開立藥物才能使用，對於市面上來路不明可以隨意購買的藥品，要多加小心 參考資料: JAMA. doi:10.1001/jama.2024.10816 # ...
... JAMA. doi:10.1001/jama.2024.10816 #減重藥物 #減重 #羅氏鮮 #康纖芙 #善纖達 #orlistat #contrave #saxenda #wegovy #zepbound #easygilife賴佳業 ...
... JAMA. 2024. doi:10.1001/jama.2024.10816 Danos like en Facebook y síguenos en nuestras redes sociales. Twitter: https://buff.ly/3HVaDxP ...
JAMA. 2024. doi:10.1001/jama.2024.10816 Danos like en Facebook y síguenos en nuestras redes sociales. Twitter: https://buff.ly/3HVaDxP ...
and health outcomes. Kushner, MD, MS, 645 N Michigan Ave, Ste 530, Chicago, IL 60611. JAMA. doi:10.1001/jama.2024.10816 ...
[URL] https://jamanetwork.com/journals/jama/fullarticle/2821290 [DOI] doi:10.1001/jama.2024.10816.
[URL] https://jamanetwork.com/journals/jama/fullarticle/2821290 [DOI] doi:10.1001/jama.2024.10816.
[URL] https://jamanetwork.com/journals/jama/fullarticle/2821290 [DOI] doi:10.1001/jama.2024.10816.
JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816 3. FDA. Adipex-P (phentermine hydrochloride) [Internet]. Updated 2024-03-28. 4 ...
doi:10.1001/jama.2023.24945 3. Gudzune KA et al. JAMA. 2024;332(7):571-584. doi:10.1001/jama.2024.10816 #Tirzepatida #Mounjaro #Obesidad ...
doi:10.1001/jama.2023.24945. 3. Gudzune KA, Kushner RF. Medications for obesity: a review. JAMA. 2024;332(7):571-584. doi:10.1001/jama.
doi:10.1001/jama.2023.19897 4. Gudzune KA, Kushner RF. Medications for Obesity: A Review. JAMA. 2024;332(7):571–584. doi:10.1001/jama.2024.10816 ...
MA
NS
DA
E
官H
SM
PB
E
猫中
EC
DJ
JM
AP
D
DF
F
A
LV
VM
AC
AP
TS
I
P
AS
TD
MI
TK
AC
SM
JA
JS
SA
VF
E
S
AC
DB
GL
DH
S
SB
H
S
H
IM
DB
LB
GO
DS
F
FS
EJ
LA
PM
ZR
PE
AW
CF
I
LC
L
N
IM
SN
I
DN
JH
FF
TS
AA
KN
VL
MT
DR
FD
D
JB
DR
AA
MS
I
TL
I
C
RN
AA
AG
EG
T
MM
FC
E
DV
A
GP
TP
LR
BL
PY
S
CM
HL
S
BB
TT
RR
EC
TD
TS
EI
RL
RY
BG
DM
A
JA
JA
LA
D
DB
J
RM
RG
SP
MM
CV
MJ
SA
IV
RA
MS
SA
MC
AD
MN
RL
BJ
A
WP
DW
HR
RM
DM
PB
SA
RA
AP
SA
PJ
CH
EI
AD
N
み
HP
DV
MA
TM
R
J
G
よ
P
DP
J
J
GJ
JC
DO
EA
IE
D
MM
G
JP
DK
MV
P
F
LG
DC
M
B
AS
A
CD
W
VG
M
AL
A
KA
K
I
S
M
SR
CI
JV
SP
JB
A
DY
C
KG
JH
M
IP
AA
MQ
RP
DB
DS
AC
XG
HA
MV
E
MS
A
AD
M
LA
VP
MR
D
G
RQ
V
MM
ZM
DC
DM